查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
专业仿製药全球市场规模研究,按类型（注射,口服,其他）,应用（肿瘤学,炎症性疾病,丙型肝炎,多发性硬化症,其他）,用途（零售,医院,其他）2022-2028区域预测
市场调查报告书
商品编码
1119099

专业仿製药全球市场规模研究,按类型（注射,口服,其他）,应用（肿瘤学,炎症性疾病,丙型肝炎,多发性硬化症,其他）,用途（零售,医院,其他）2022-2028区域预测

Global Specialty Generics Market Size study, by Type (Injectables, Oral Drugs, Others), By Application (Oncology, Inflammatory Conditions, Hepatitis C, Multiple Sclerosis, Others) by End-use (, Retail, Hospital, Others) and Regional Forecasts 2022-2028
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球特种仿製药市场价值约为 672 亿美元，预计在 2022-2028 年的预测期内将以超过 9.20% 的健康增长率增长。

当一种特殊药物的专利到期时，它会被一种仿製药取代。这些药物用于治疗慢性或复杂的医学问题，如癌症、自身免疫性疾病、癫痫和艾滋病毒。治疗丙型肝炎等复杂慢性疾病的特殊仿製药的接受和广泛采用是市场的关键驱动力。根据世界卫生组织（WHO）2022年报告，全球有超过5800万人感染慢性丙型肝炎病毒，每年约有150万人感染。由于免疫系统减弱和多种合併症，衰老是增加关节炎、心血管疾病和癌症等复杂慢性疾病发病率的重要危险因素。根据世界卫生组织 (WHO) 的预测，老年人口将从 2020 年的 10 亿增加到 2021 年的 14 亿，到 2030 年，地球上六分之一的人将超过 60 岁。到 2030 年，预计地球上六分之一的人口将超过 60 岁，随着老龄化人口的增长，预计可实现盈利增长。大型製药公司正在进行併购以增加其市场份额。 Biosena 于 2021 年 10 月收购了辉瑞 (Pfizer) 拥有的一家澳大利亚工厂，用于生产药物疗法。 BioCena 还于 2020 年完成了对 Hospira Adelaide 旗下辉瑞的收购。该公司是美国 200 种特种仿製药注射剂的领先供应商。预计此类战略活动将在预测期内推动市场增长。然而，新进入者的障碍包括品牌知名度和忠诚度、特种仿製药的高度复杂性以及有限的盈利能力，所有这些都导致□□处方成本上升。例如，梯瓦为多发性硬化症 (MS) 患者提供了智能共付卡，以购买药物 Copaxone。 Teva 向多发性硬化症 (MS) 患者提供智能共付卡以购买药物 Copazone。此类活动将客户的注意力转移到品牌产品上，并减少了特殊通用产品的销售。

在全球特种仿製药市场研究中考虑的主要地区是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。北美凭藉对新药批准的有利监管法律主导了特种仿製药市场，占 2021 年总收入的 36.5%。美国 FDA 已经发起了许多尝试来改进整体批准程序。因此，美国食品药品监督管理局 (FDA) 根据 Hatch-Waxman 法案提出了仿製药用户费用修正案 (GDUFA)，以加快向公众提供安全、有效和负担得起的仿製药。因此，知名製造商不断努力将特殊仿製药推向市场。例如，2022 年 6 月，Amneal Pharmaceuticals Inc. 推出了获美国 FDA 批准用于治疗多发性硬化症和其他脊髓疾病的特殊药物 LYVISPAH（巴氯芬）。

本报告中包含的主要市场参与者是：

梯瓦製药工业有限公司

Viatris Inc.

诺华公司（Sand International GmbH）

棕熊製药公司

海军陆战队

博世健康公司（Valiant Pharmaceuticals International Inc.）

女士实验室有限公司

远籐製药公司

Apotex 公司

Sun Pharmaceutical Industries, Inc.

本研究的目的是确定近年来各个细分市场和国家/地区的市场规模，并预测未来八年的价值。该报告旨在捕捉所研究的每个地区和国家的行业的定性和定量方面。此外，它还提供了有关关键方面的详细信息，例如定义市场未来增长的驱动因素和挑战。此外，报告还应详细分析主要参与者的竞争格局和产品供应，以及微观市场中可供利益相关者投资的机会。市场的详细细分和子细分如下所述。

按类型

注射

口服药物

杂项

按应用程序

肿瘤学

炎症性疾病

丙型肝炎

多发性硬化症

杂项

按最终用户

零售

医院

杂项

按地区

北美

美国

加拿大

欧洲

英国

德国

法国

西班牙

意大利

其他欧洲

亚太地区

中国

印度

日本

澳大利亚

韩国

其他亚太地区

拉丁美洲

巴西

墨西哥

世界其他地方

此外，本研究考虑的年份是：

实际年份 - 2018 年、2019 年、2020 年

2021 年基准年

预测期 - 2022 年 至 2028 年

本报告的目标受众，全球特种仿製药市场

主要咨询公司和顾问

大公司、中型公司、中小企业

风险投资

增值经销商 (VAR)

第三方知识提供者

投资银行家

投资者

内容

第 1 章执行摘要

  • 市场快照
  • 2020-2028 年全球市场和细分市场的估计和预测
    • 专业仿製药市场：按地区分列，2020-2028 年
    • 专业仿製药市场：按类型划分，2020-2028 年
    • 按应用划分的特殊仿製药市场：2020-2028
    • 专业仿製药市场：按最终用途分类，2020-2028 年
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章全球市场定义和专业仿製药的范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 调查年份
  • 货币兑换率

第 3 章专业仿製药的全球市场动态

  • 专业通用市场影响分析（2020-2028 年）
    • 市场驱动力
      • 特殊仿製药在復杂慢性疾病治疗中的应用增加
      • 关节炎、心血管疾病和癌症等复杂慢性疾病的患病率不断上升
    • 市场挑战
      • 专业仿製药的高度复杂性
    • 市场机会
      • 配方的进步

第 4 章专业仿製药的全球市场行业分析

  • 波特的 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
    • 波特 5 力模型的未来方法（2018-2028）
  • PEST 分析
    • 政治
    • 经济
    • 社交
    • 技术
  • 招商引资模式
  • 分析师的结论和建议
  • 热门投资机会
  • 制胜法宝

第 5 章风险评估：COVID-19 的影响

    • 评估 COVID-19 对行业的整体影响
    • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章。全球特种仿製药市场：按类型分类

  • 市场快照
  • 全球特殊仿製药市场：按类型划分的表现 - 潜力分析
  • 2018-2028 年全球特种仿製药市场类型的估计和预测
  • 专业仿製药市场、细分市场分析
    • 注入
    • 口服药
    • 其他

第 7 章：全球特种仿製药市场：按应用分类

  • 市场快照
  • 全球特种仿製药市场：按应用进行的性能和潜力分析
  • 2018-2028 年全球特种仿製药市场、估计和预测（按应用）
  • 全球特种仿製药市场，细分分析
    • 肿瘤学
    • 炎症性疾病
    • 丙型肝炎
    • 多发性硬化症
    • 其他

第 8 章。全球特种仿製药市场：按最终用途分类

  • 市场快照
  • 全球特种仿製药市场：按最终用途分列的性能和潜力分析
  • 2018-2028 年全球特种仿製药市场、估计和预测（按最终用途）
  • 专业仿製药市场、细分市场分析
    • 医院
    • 零售药房
    • 其他

第 9 章。全球专业和仿製药市场：区域分析

  • 专业仿製药区域市场概况
  • 北美
    • 美国
      • 按类型划分的估计和预测，2018-2028 年
      • 按应用划分的估计和预测，2018-2028
      • 按最终用途分类的估计和预测，2018-2028 年
    • 加拿大
  • 欧洲特种仿製药市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲地区
  • 亚太专业仿製药市场概览
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲特种仿製药市场概况
    • 巴西
    • 墨西哥
  • 世界其他地区

第 10 章衝突信息

  • 顶级市场策略
  • 公司简介
    • 梯瓦製药工业有限公司
      • 主要信息
      • 概览
      • 财务（如果有数据）
      • 产品概览
      • 近期发展状况
    • Viatris Inc.
    • Novartis AG（Sandoz International GmbH）
    • Hikma Pharmaceuticals PLC
    • Mallinckrodt
    • Bausch Health Companies Inc.（Valeant Pharmaceuticals International, Inc.）
    • Dr. Reddy's Laboratories Ltd.
    • Endo Pharmaceuticals Inc.
    • Apotex Corp.
    • Sun Pharmaceutical Industries Ltd.

第 11 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场估算
    • 验证
    • 出版
  • 调查属性
  • 调查先决条件

Global Specialty Generics Market is valued approximately USD 67.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.20% over the forecast period 2022-2028. When a specialty drug's patent expires, it's replaced with a generic version. These medications are used to treat chronic or complicated medical problems such as cancer, autoimmune disorders, epilepsy, and HIV. The growing acceptance of specialty generic drugs for the treatment of complicated chronic illnesses such as hepatitis C, as well as their increasing prevalence, is a significant market driver. According to the World Health Organization (WHO) report 2022, over 58 million individuals worldwide have chronic hepatitis C virus infection, with approximately 1.5 million persons infected yearly. Due to weakened immunity and high comorbid conditions, age is a key risk factor for the increased incidence of complicated chronic illnesses such as arthritis, cardiovascular disease, and cancer. According to the World Health Organization (WHO) the elderly population climbed from 1 billion in 2020 to 1.4 billion in 2021., By 2030, one in every six persons on the planet will be 60 or older. As a result, the industry's fast rising senior population is likely to generate profitable growth prospects. To increase their market share, major pharmaceutical corporations have engaged in mergers and acquisitions. BioCena bought a Pfizer-owned Australian factory for medication therapy manufacture in October 2021. In addition, BioCena finalized the acquisition of Pfizer Inc., which is owned by Hospira Adelaide, in 2020. It is a major provider of 200 specialized generic injectables in the United States. During the projected period, such strategic activities are expected to fuel market growth. However, brand recognition and loyalty, the high complexity of specialty generic goods, and limited profitability are some of the key entry obstacles for new participants in the business, all of which contribute to growing prescription costs. Teva Pharmaceutical Industries Ltd., for example, provided smart co-pay cards to Multiple Sclerosis (MS) sufferers in order for them to purchase COPAXONE for their treatment. Cardholders who qualify receive medications at no cost. Such campaigns draw customers' attention to their branded items, reducing the sales of specialist generic products.

The key regions considered for the Global Specialty Generics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the speciality generics market due to favourable regulatory laws governing the approval of new drugs, and contributed 36.5% of total revenue in 2021. The FDA in the United States has launched many attempts to improve the overall approval process. As a result, the United States Food and Drug Administration (FDA) proposed Generic Drug User Fee Amendments (GDUFA) under the Hatch-Waxman Act to accelerate the delivery of safe and effective low-cost generic medications to the public. As a result, prominent manufacturers are always working to commercialise specialty generic medications in the market. Amneal Pharmaceuticals Inc., for example, introduced LYVISPAH (baclofen) in June 2022, a specialty medication approved by the US FDA for the treatment of multiple sclerosis and other spinal cord illnesses.

Major market player included in this report are:

Teva Pharmaceuticals Industries Ltd.

Viatris Inc.

Novartis AG (Sandoz International GmbH)

Hikma Pharmaceuticals PLC

Mallinckrodt

Bausch Health Companies Inc. (Valeant Pharmaceuticals International, Inc.)

Dr. Reddy's Laboratories Ltd.

Endo Pharmaceuticals Inc.

Apotex Corp.

Sun Pharmaceutical Industries Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type

Injectables

Oral Drugs

Others

By Application:

Oncology

Inflammatory Conditions

Hepatitis C

Multiple Sclerosis

Others

By End-use:

Retail

Hospital

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Specialty Generics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Specialty Generics Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Specialty Generics Market, by Type, 2020-2028 (USD Billion)
    • 1.2.3. Specialty Generics Market, by Application, 2020-2028 (USD Billion)
    • 1.2.4. Specialty Generics Market, by End-use, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Specialty Generics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Specialty Generics Market Dynamics

  • 3.1. Specialty Generics Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing adoption of specialty generic medicines for the treatment of complex chronic diseases.
      • 3.1.1.2. Rising prevalence of complex chronic diseases such as arthritis, cardiovascular diseases, and cancer
    • 3.1.2. Market Challenges
      • 3.1.2.1. High complex nature of specialty generic products
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in Formulation

Chapter 4. Global Specialty Generics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Specialty Generics Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Specialty Generics Market by Type, Performance - Potential Analysis
  • 6.3. Global Specialty Generics Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
  • 6.4. Specialty Generics Market, Sub Segment Analysis
    • 6.4.1. Injectables
    • 6.4.2. Oral Drugs
    • 6.4.3. Others

Chapter 7. Global Specialty Generics Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Specialty Generics Market by Application, Performance - Potential Analysis
  • 7.3. Global Specialty Generics Market Estimates & Forecasts by Application 2018-2028 (USD Billion)
  • 7.4. Specialty Generics Market, Sub Segment Analysis
    • 7.4.1. Oncology
    • 7.4.2. Inflammatory Conditions
    • 7.4.3. Hepatitis C
    • 7.4.4. Multiple Sclerosis
    • 7.4.5. Others

Chapter 8. Global Specialty Generics Market, by End-use

  • 8.1. Market Snapshot
  • 8.2. Global Specialty Generics Market by End-use, Performance - Potential Analysis
  • 8.3. Global Specialty Generics Market Estimates & Forecasts by End-use 2018-2028 (USD Billion)
  • 8.4. Specialty Generics Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Others

Chapter 9. Global Specialty Generics Market, Regional Analysis

  • 9.1. Specialty Generics Market, Regional Market Snapshot
  • 9.2. North America Specialty Generics Market
    • 9.2.1. U.S. Specialty Generics Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. End-use breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Specialty Generics Market
  • 9.3. Europe Specialty Generics Market Snapshot
    • 9.3.1. U.K. Specialty Generics Market
    • 9.3.2. Germany Specialty Generics Market
    • 9.3.3. France Specialty Generics Market
    • 9.3.4. Spain Specialty Generics Market
    • 9.3.5. Italy Specialty Generics Market
    • 9.3.6. Rest of Europe Specialty Generics Market
  • 9.4. Asia-Pacific Specialty Generics Market Snapshot
    • 9.4.1. China Specialty Generics Market
    • 9.4.2. India Specialty Generics Market
    • 9.4.3. Japan Specialty Generics Market
    • 9.4.4. Australia Specialty Generics Market
    • 9.4.5. South Korea Specialty Generics Market
    • 9.4.6. Rest of Asia Pacific Specialty Generics Market
  • 9.5. Latin America Specialty Generics Market Snapshot
    • 9.5.1. Brazil Specialty Generics Market
    • 9.5.2. Mexico Specialty Generics Market
  • 9.6. Rest of The World Specialty Generics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Teva Pharmaceuticals Industries Ltd
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Viatris Inc.
    • 10.2.3. Novartis AG (Sandoz International GmbH)
    • 10.2.4. Hikma Pharmaceuticals PLC
    • 10.2.5. Mallinckrodt
    • 10.2.6. Bausch Health Companies Inc. (Valeant Pharmaceuticals International, Inc.)
    • 10.2.7. Dr. Reddy's Laboratories Ltd.
    • 10.2.8. Endo Pharmaceuticals Inc.
    • 10.2.9. Apotex Corp.
    • 10.2.10. Sun Pharmaceutical Industries Ltd.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Specialty Generics Market, report scope
  • TABLE 2. Global Specialty Generics Market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global Specialty Generics Market estimates & forecasts by Type 2018-2028 (USD Billion)
  • TABLE 4. Global Specialty Generics Market estimates & forecasts by Application 2018-2028 (USD Billion)
  • TABLE 5. Global Specialty Generics Market estimates & forecasts by End-use 2018-2028 (USD Billion)
  • TABLE 6. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 7. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 8. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 9. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global Specialty Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. Global Specialty Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. U.S. Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 17. U.S. Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 18. U.S. Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 19. Canada Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 20. Canada Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 21. Canada Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 22. UK Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 23. UK Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 24. UK Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 25. Germany Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 26. Germany Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 27. Germany Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 28. RoE Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 29. RoE Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 30. RoE Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 31. China Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 32. China Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 33. China Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 34. India Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 35. India Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 36. India Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 37. Japan Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 38. Japan Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 39. Japan Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 40. RoAPAC Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 41. RoAPAC Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 42. RoAPAC Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 43. Brazil Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 44. Brazil Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 45. Brazil Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 46. Mexico Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 47. Mexico Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 48. Mexico Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 49. RoLA Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 50. RoLA Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 51. RoLA Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 52. Row Specialty Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 53. Row Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 54. Row Specialty Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of global Specialty Generics Market
  • TABLE 56. List of primary sources, used in the study of global Specialty Generics Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Specialty Generics Market, research methodology
  • FIG 2. Global Specialty Generics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Specialty Generics Market, key trends 2021
  • FIG 5. Global Specialty Generics Market, growth prospects 2022-2028
  • FIG 6. Global Specialty Generics Market, porters 5 force model
  • FIG 7. Global Specialty Generics Market, pest analysis
  • FIG 8. Global Specialty Generics Market, value chain analysis
  • FIG 9. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global Specialty Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global Specialty Generics Market, regional snapshot 2018 & 2028
  • FIG 15. North America Specialty Generics Market 2018 & 2028 (USD Billion)
  • FIG 16. Europe Specialty Generics Market 2018 & 2028 (USD Billion)
  • FIG 17. Asia pacific Specialty Generics Market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America Specialty Generics Market 2018 & 2028 (USD Billion)
  • FIG 19. Global Specialty Generics Market, company Market share analysis (2021)